2023
Exports
$53.6MWorld Rnk 50 / 208
Flag Rnk 235 / 1203
2023
PRODUCT COMPLEXITY IN Vaccines, blood, antisera, toxins and cultures
1.25Rnk 89 / 1025
2023
Imports
$1.04BWorld Rnk 35 / 222
Flag Rnk 17 / 1213
2023
ECONOMIC COMPLEXITY of Romania
1.02Rnk 28 / 132

About

Exports In 2023, Romania exported $53.6M in Vaccines, blood, antisera, toxins and cultures, making it the 50th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 235th most exported product in Romania. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Romania are: Germany ($23M), Czechia ($11.2M), Lithuania ($4.74M), Bulgaria ($2.79M), and Latvia ($1.79M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Romania between 2022 and 2023 were Germany ($6.82M), Czechia ($5.81M), and Ireland ($1.72M).

Imports In 2023, Romania imported $1.04B in Vaccines, blood, antisera, toxins and cultures, becoming the 35th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 17th most imported product in Romania. Romania imports Vaccines, blood, antisera, toxins and cultures primarily from: Germany ($290M), Netherlands ($239M), Hungary ($142M), Switzerland ($121M), and Belgium ($63M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Romania between 2022 and 2023 were Hungary ($55.2M), South Korea ($19.9M), and Netherlands ($15.9M).

Latest Trends

Jan 2025

Subnational Monthly Trade

View
Flow
Y-AXIS SCALE

For a full breakdown of trade patterns, visit the trend explorer or the product in country profile.

The following visualization shows the latest trends on Vaccines, blood, antisera, toxins and cultures. Countries are shown based on data availability.

* Using January 2020 exchange rates when trade data is reported in local currency.

Explore Latest Trends

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Trade Balance

Color
EXPORTS (2023)$53.6M
IMPORTS (2023)$1.04B
NET TRADE (2023)-$988M

In 2023, Romania exported $53.6M in Vaccines, blood, antisera, toxins and cultures. The main destinations of Romania exports on Vaccines, blood, antisera, toxins and cultures were Germany ($23M), Czechia ($11.2M), Lithuania ($4.74M), Bulgaria ($2.79M), and Latvia ($1.79M).

In 2023, Romania imported $1.04B in Vaccines, blood, antisera, toxins and cultures, mainly from Germany ($290M), Netherlands ($239M), Hungary ($142M), Switzerland ($121M), and Belgium ($63M).

Explore Visualizations

Export Destinations (2023)

Import Origins (2023)

Market Growth

Flow
THE FASTEST GROWING Vaccines, blood, antisera, toxins and cultures EXPORT MARKETS FOR Romania WERE (2022 - 2023):
Germany$6.82M (42.3%)
Czechia$5.81M (108%)
Ireland$1.72M (11.1k%)
THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Vaccines, blood, antisera, toxins and cultures BY Romania WERE (2022 - 2023):
United States-$40M (-99.8%)
France-$932k (-94.5%)
Turkey-$568k (-77%)

Change in Exports by Market (2022 - 2023)

Market Concentration

View
Flow
Type
In 2023, Romania's main exporting competitors in Vaccines, blood, antisera, toxins and cultures were:
In 2023, Romania's main importing competitors in Vaccines, blood, antisera, toxins and cultures were:

Explore Visualizations

Trade Value of Vaccines, blood, antisera, toxins and cultures by Exporters

Potential Exports

Potential Exports

Flow
View
TOP EXPORT POTENTIALUnited States+ $30.7M
TOP IMPORT POTENTIALBelgium+ $52.3M

Vaccines, blood, antisera, toxins and cultures’s highest export potential is United States. With an export gap of $30.7M.   Vaccines, blood, antisera, toxins and cultures’s highest import potential is Belgium with an import gap of $52.3M.

See methodology.

Subscribe today to OEC pro and access the latest data

Sign Up

Have questions, comments, or concerns?
Send us an e-mail: support@oec.world
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with